Memphis Medical News: Wei Li, PhD, professor in the Department of Pharmaceutical Sciences in the University of Tennessee Health Science Center’s College of Pharmacy, has been appointed a UTHSC Distinguished Professor. The title is reserved for those who have contributed in a superlative way to UTHSC and brought distinction and respect to the university.
The University of Tennessee Health Science Center and Regional One Health have announced they are partnering on a clinical trial program including two late-stage clinical trials evaluating Regeneron’s REGN-COV2, the company’s investigational two-antibody cocktail for the treatment and prevention of COVID-19.
In March 2020, a deliberate misinformation campaign spread fear among the American public by propagating the false story that a nationwide quarantine to contain the coronavirus pandemic was imminent.
Shelby County’s District Attorney says the number of teens committing violent crimes is on the rise. “How do we make sure our kids stay off the wrong path? And if they put one toe that wrong path how do we get them off their quickly to save their lives and the lives of others in… Read More
President Donald Trump said it’s a cure for COVID-19 and that same treatment will be used in Memphis in an upcoming clinical trial.
Lab equipment owned by the Shelby County Health Department will receive new life while loaned to LeMoyne-Owen College and the University of Tennessee Health Science Center, as the department partners with institutions that share and promote its mission.
Since the COVID-19 pandemic began, vaccination rates for children have dropped precipitously compared to the same time last year. Many parents and caregivers have delayed visits to their pediatrician’s office because of understandable concerns about COVID-19 transmission.
Jonathan Wall, PhD, professor in the University of Tennessee Health Science Center’s Graduate School of Medicine in Knoxville and director of the Amyloidosis and Cancer Theranostics, has been awarded a two-year grant totaling $385,000 from the National Institute on Aging, part of the National Institutes of Health to study new treatments for systemic amyloidosis. Also:… Read More
